日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.

HCCS1 武装的、四重调控的溶瘤腺病毒,特异性靶向肝癌,作为一种癌症靶向基因病毒治疗策略

Xu Hai-Neng, Huang Wei-Dan, Cai Ying, Ding Miao, Gu Jin-Fa, Wei Na, Sun Lan-Ying, Cao Xin, Li Hua-Guang, Zhang Kang-Jian, Liu Xin-Ran, Liu Xin-Yuan